Open-label study of cognitive behavioural therapy for individuals with at-risk mental state: Feasibility in the Japanese clinical setting

Kazunori Matsumoto*, Noriyuki Ohmuro, Naohisa Tsujino, Shimako Nishiyama, Koichi Abe, Yumiko Hamaie, Masahiro Katsura, Naomi Inoue, Hiroo Matsuoka, Yasuhiro Kawasaki, Toshifumi Kishimoto, Michio Suzuki, Masafumi Mizuno

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Aim: To date, most cognitive behavioural therapy (CBT) trials for individuals with at-risk metal state (ARMS) have been conducted in few Western countries and its feasibility in other regions, including Japan, has not been established. Methods: We designed an open-label pilot study. Fourteen ARMS participants received CBT over 6 months and were followed-up for 6 months. Results: Thirteen individuals completed the CBT intervention and assessments. The mean total score on the Positive and Negative Syndrome Scale improved from 60.2 to 46.0 after the intervention (Cohen's d = 1.1). The effects were maintained at the follow-up assessment. One participant transitioned to psychosis after the CBT intervention, and was the only patient who received antipsychotics. Conclusions: We confirmed the feasibility of the provision of CBT for ARMS in Japan. Since overprescription of antipsychotics is a matter of great concern in Japan, CBT could be a valuable alternative treatment strategy.

Original languageEnglish
Pages (from-to)137-141
Number of pages5
JournalEarly Intervention in Psychiatry
Volume13
Issue number1
DOIs
StatePublished - 2019/02

Keywords

  • at-risk mental state
  • cognitive behavioural therapy
  • early intervention
  • psychological treatment
  • psychosis

ASJC Scopus subject areas

  • Psychiatric Mental Health
  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'Open-label study of cognitive behavioural therapy for individuals with at-risk mental state: Feasibility in the Japanese clinical setting'. Together they form a unique fingerprint.

Cite this